Treatment Action Group, AIDS Vaccine Advocacy Coalition, and the Global HIV Vaccine Enterprise invite you to a dynamic roundtable discussion, "Community and Scientific Perspectives on the Future of AIDS Research," to be held on May 18, 2009, HIV Vaccine Awareness Day, at the headquarters of the Treatment Action Group (TAG), 611 Broadway (corner of Broadway & Houston), Suite 308 (Directions). Reception to follow.

  • 4:30 - 4:45: Arrival and welcome (Alan Bernstein, Global HIV Vaccine Enterprise Executive Director)

  • 4:45 - 5:00: Framing the discussion (Mitchell Warren, AVAC Executive Director)

  • 5:00 - 5:45: Panel: Frontline Perspectives on the Future of AIDS Research (moderated by Emily Bass, AVAC Program Director)
    Panelists include:
    • Damon Humes, Executive Director, Men of Color Health Awareness Project (MOCHA)
    • Kenyon Farrow, National Public Education Director, Queers for Economic Justice and Policy Institute Fellow, National Gay & Lesbian Taskforce
    • Waheedah Shabazz-El, Community Organizer and Trainer, Community HIV/AIDS Mobilization Project (CHAMP)
    • Kimberleigh Smith, Director, Women's Institute, Gay Men's Health Crisis (GMHC)

  • 5:45 - 6:30: Panel: Future Directions of AIDS Research –Scientific Researchers’ Perspectives on the Future of AIDS Research (moderated by Mark Harrington, TAG Executive Director)
    Panelists include:
    • Timothy Cardozo, Assistant Professor, Department of Pharmacology, Langone Medical Center, New York University School of Medicine
    • Roy (Trip) Gulick, Chief, Division of Infectious Diseases, Department of Medicine; Professor of Medicine at Weill Medical College of Cornell University and Attending Physician at the New York-Presbyterian Hospital.
    • Beryl Koblin, Head, Laboratory of Infectious Disease Prevention, New York Blood Center
    • Adrian McDermott, Director, Immunobiology & Vaccine Discovery, International AIDS Vaccine Initiative (IAVI)
    • Sarah Schlesinger, Associate Professor of Clinical Investigation, Laboratory of Cellular Physiology and Immunology, The Rockefeller University

  • 6:30 - 6:45: Closing remarks (Mark Harrington)

  • 6:45 on: Reception

Your RSVP by email is requested. Please email to confirm your participation.


AVAC, TAG, and the Global HIV Vaccine Enterprise